Rapid C-reactive protein and white cell tests decrease cost and shorten emergency visits

Eeva Kokko1, Matti Korppi, Merja Helminen

  • 1Tampere Centre for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Insights

Rapid testing for white blood cells (WBC) and C-reactive protein (CRP) in children significantly reduces emergency room (ER) stays and costs. This approach is effective when no further examinations or emergency treatments are required.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Pathology
  • Health Economics

Background:

  • Elevated white blood cells (WBC) and C-reactive protein (CRP) are common, non-specific indicators of bacterial infection in children.
  • Current diagnostic methods can lead to prolonged patient stays and increased healthcare expenses.

Purpose of the Study:

  • To evaluate the impact of rapid WBC and CRP testing on patient flow within pediatric emergency rooms (ERs).
  • To assess the cost-effectiveness of rapid WBC and CRP testing compared to traditional laboratory methods.

Main Methods:

  • Retrospective chart review of 166 children treated in a pediatric ER over 3 months.
  • Analysis of the association between rapid WBC/CRP testing and emergency department length of stay.
  • Comparison of rapid test costs versus standard hospital laboratory costs.

Main Results:

  • Median ER stay was significantly shorter with rapid testing (142.5-147.5 min) compared to laboratory tests or emergency treatment (179.5-201.5 min).
  • Rapid testing costs were only 41.5% of the equivalent laboratory testing costs.
  • These benefits were most pronounced in children discharged without further examinations or emergency interventions.

Conclusions:

  • Simultaneous rapid testing for CRP and WBC effectively decreases costs and shortens ER stays for children with suspected infections.
  • Rapid testing offers a cost-saving alternative, costing less than half of traditional laboratory analysis.
  • Implementation of rapid testing can optimize patient flow and resource allocation in pediatric ER settings.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
633
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56